Blood-Based MRD Testing Identifies AML Patients at Risk of Relapse After Stem Cell Transplant
Researchers looked at AML variants in the blood of patients prior to their allogeneic hematopoietic cell transplant and correlated them with subsequent relapse or death.
Cardiac-Related Consequences of Alcohol Flushing Genetic Variant Reduced by Drug
With endothelial cells derived from induced pluripotent stem cells, researchers tracked functional changes and potential treatment targets in alcohol flushing variant carriers.
Five research groups participating in the NHGRI-funded Molecular Phenotypes of Null Alleles in Cells initiative aim to characterize 1,000 null alleles in a pilot phase.
Pluristyx, Pancella, Implant Therapeutics Agree to Merge
The merged company, which will retain the Pluristyx name, will provide induced pluripotent stem cell-related products and services.
CareDx Receives CE Mark for Hematopoietic Cell Transplantation Testing Kit, Analysis Software
The designation furthers the firm's expansion into the stem cell transplant space, which began with the launch of AlloCell in 2020.